Company Directory > Digital Health > Cerebras Systems
Cerebras Systems is a leading artificial intelligence (AI) infrastructure company that designs and builds the world's most powerful AI supercomputers for massive-scale deep learning. The company is famous for creating the 'Wafer-Scale Engine' (WSE), the largest and fastest AI processor ever built, which integrates an entire silicon wafer's worth of compute and memory into a single chip. This architecture eliminates the traditional communication bottlenecks found in clusters of standard GPUs. In the pharmaceutical and life sciences sectors, Cerebras technology is utilized to radically accelerate drug discovery, molecular modeling, and genomic research. By providing orders of magnitude faster compute than legacy systems, Cerebras enables researchers at organizations like GSK, AstraZeneca, and the Mayo Clinic to train complex models (such as transformer-based language models for proteins or epigenomics) in hours or days rather than weeks or months. The company operates both as a hardware provider and a cloud-based inference-as-a-service platform.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:AI for Drug Discovery & Biomedical Research
SIZE & FINANCIALS
Employees:501-1000
Revenue:$200M-$500M
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Series G
Total Raised:$1.55B
Investors:Fidelity Investments, Benchmark, Coatue Management, Vy Capital, Altimeter Capital, Alpha Wave Global, Atreides Management, Eclipse Ventures, Foundation Capital
STOCK
Exchange:NASDAQ
Ticker:CBRS (Reserved)
Market Cap:$8.1B (Estimated Valuation)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Technology Provider)
Modalities:AI-driven Small Molecule Discovery, Peptide Therapeutics, Epigenomic Language Models, Large Language Models (Biomedical NLP)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:GSK (Accelerating genetic and genomic research), AstraZeneca (Reducing drug discovery training time from weeks to days), AbbVie (Biomedical NLP and natural language translation services), Mayo Clinic (Generative AI for diagnostic and treatment insights), Peptilogics (Accelerating development of novel peptide therapeutics), Argonne National Laboratory (Gordon Bell Prize-winning COVID-19 research), nference (Processing unstructured medical data for clinical insights)
COMPETITION
Position:Leader
Competitors:NVIDIA, Graphcore, Groq, SambaNova Systems, Intel (Habana Labs), AMD
LEADERSHIP
Key Executives:
Andrew Feldman - CEO and Co-Founder
Gary Lauterbach - CTO Emeritus and Co-Founder
Sean Lie - CTO and Co-Founder
Bob Komin - SVP and CFO
Scientific Founders:Andrew Feldman, Gary Lauterbach, Michael James, Sean Lie, Jean-Philippe Fricker
Board Members:Glenda Dorchak (Former Intel/IBM executive), Paul Auvil (Former CFO of VMWare), Jeff Rothschild (Former VP Engineering at Facebook), Pradeep Sindhu (Founder of Juniper Networks), Ilya Sutskever (Co-founder of OpenAI)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cerebras Systems. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.